Tumor Ablation is estimated to be over US$ 545.3 Mn in 2018. It is anticipated to grow at 11.1% CAGR from 2019 to 2030.
The significant growth of the market can be attributed to growing number of geriatric population followed by increasing number of cancer patients. Moreover, technological advancements in ablation devices in emerging countries, is anticipated to boost the growth of the tumor ablation market over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent.
Major Key Players of the Tumor Ablation Market are:
Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others.
No comments:
Post a Comment